Sentara Norfolk General Emergency Department
Norfolk, Virginia, 23507, United States
NCT Number: NCT01662843
The B-RIPPED scan is a standardized ultrasound evaluation of pulmonary B-lines, Right ventricle size and strain, Inferior Vena Cava collapsibility, Pleural and Pericardial Effusion, Pneumothorax, Ejection Fraction, and lower extremity Deep Venous Thrombosis. Primary outcomes measured are the magnitude of change in differential diagnoses.
Looking for future studies?
Notify Me18 year–89 year
All sexes
Observational
Norfolk, Virginia, 23507, United States
This prospective randomized control trial will be performed on a convenience sample of 200 patients presenting with undifferentiated SOB to an academic emergency department (ED) (volume 56,000 patients/year). Subjects are excluded if they have a known history of asthma, are 20 or more weeks pregnant, or have had thoraco-abdominal trauma in the past 72 hours. The BRIPPED pilot investigation (IRB #10-02-FB-0026) enrolled 43 patients and physician subjects from 4/30/2010 to 1/20/2011. This study differs in methodology from the pilot study in the reduction of the total number of ultrasound images obtained to decrease the total time to perform the scan. Instead of a cohort study, this randomized control trial includes the addition of a control group for cost and time saved comparison. As in the pilot study, eligible patients will be evaluated by the treating ED physician who will rank potential diagnoses from most to least likely. A study investigator performs the B-RIPPED scan and provides the initial treating physician with the results. The treating physician will again be asked to complete a differential diagnosis ranking knowing the B-RIPPED results. Changes in the differential diagnosis ranking, physician orders, and interventions will be compiled. A randomized control cohort will be assigned for eligible patients. In the control group, the treating physician will complete the diagnosis rank list prior to the completion of the workup, and then once all lab values are back. Time to disposition, and comparison of labs and radiology tests ordered will be compared to the cohort receiving the BRIPPED scan. Patients will be assigned a number at time of enrollment, which randomly assigns them to the control or experimental (patients receiving the BRIPPED scan) group. Packets containing the appropriate data collection form (control or experimental) will be organized so even numbered patients will belong to one group, and odd numbered patients will be assigned to the other.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Subjects are included if they are between the ages of 18-89 and present to the Emergency Department with a chief complaint of shortness of breath or dyspnea.
Exclusion criteria
Time frame: duration of ED course, which is expected to be an average of 3 hours
Time frame: 3 to 30 minutes during the ED course
Time frame: duration of ED course, which is expected to be an average of 3 hours, with a range of 45 minutes to 6 hours
Time frame: duration of the ED course, which is expected to be an average of 3 hours, with a range of 45 minutes to 6 hours
Time frame: 30 days after presentation to ED
Electronic medical record review of patients who present with shortness of breath 30 days after initial presentation, evaluation and treatment
Eastern Virginia Medical School
Other
BRIPPED Scan for Evaluation of Emergency Department Patients With Shortness of Breath
Acronym: BRIPPED
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05787665
Disease Attributes, Dyspnea
Lyon, France
View Trial DetailsNCT05742113
Disease Attributes, Dyspnea
Manisa, Turkey (Türkiye)
View Trial DetailsNCT04223297
Disease Attributes, Dyspnea
Amiens, France
View Trial DetailsNCT04119505
Acute Respiratory Failure, Disease Attributes
Montpellier, France
View Trial Details